Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Critical Care
Published in: Critical Care 2/2013

01-04-2013 | Commentary

Glycemic control in the critically ill - 3 domains and diabetic status means one size does not fit all!

Author: James S Krinsley

Published in: Critical Care | Issue 2/2013

Login to get access

Abstract

Hyperglycemia, hypoglycemia, and increased glucose variability have each been shown to be independently associated with increased risk of mortality in the critically ill. Sechterberger and colleagues have completed a large observational cohort study that demonstrates that diabetic status modulates these relationships in clinically meaningful ways. These findings corroborate, in a strikingly consistent manner, those of another very recently published large observational study.
Literature
1.
Sechterberger MK, Bosman RJ, Oudemans-van Straaten HM, Siegelaar SE, Hermanides J, Hoekstra JB, Devries JH: The effect of diabetes mellitus on the association between measures of glycemic control and intensive care mortality: a retrospective cohort study. Crit Care 2013, 17: R52. 10.1186/cc12572PubMedCentralCrossRefPubMed
2.
Krinsley JS, Egi M, Kiss A, Amin DN, Schuetz P, Maurer P, Schultz M, van Hooifdonk R, Kiyoshi M, Mackenzie I, Annane D, Stow P, Nasraway S, Holewinski S, Holzinger U, Preiser JC, Vincent JL, Bellomo R: Diabetic status and the relationship of the 3 domains of glycemic control to mortality in critically ill patients: an international multi-center cohort study. Crit Care 2013, 17: R37. 10.1186/cc12547PubMedCentralCrossRefPubMed
3.
Van den Berghe G, Wouters P, Weekers F, Verwaest C, Bruyninckx F, Schetz M, Vlasselaers D, Ferdinande P, Lauwers P, Bouillon R: Intensive insulin therapy in the critically ill patients. N Engl J Med 2001, 345: 1359-1367. 10.1056/NEJMoa011300CrossRefPubMed
4.
Garber AJ, Moghissi ES, Bransome ED Jr, Clark NG, Clement S, Cobin RH, Furnary AP, Hirsch IB, Levy P, Roberts R, Van den Berghe G, Zamudio V, American College of Endocrinology Task Force on Inpatient Diabetes Metabolic Control: American College of Endocrinology position statement on inpatient diabetes and metabolic control. Endocr Pract 2004, 10: 77-82.CrossRefPubMed
5.
NICE-SUGAR Study Investigators, Finfer S, Chittock DR, Su SY, Blair D, Foster D, Dhingra V, Bellomo R, Cook D, Dodek P, Henderson WR, Hébert PC, Heritier S, Heyland DK, McArthur C, McDonald E, Mitchell I, Myburgh JA, Norton R, Potter J, Robinson BG, Ronco JJ: Intensive versus conventional glucose control in critically ill patients. N Engl J Med 2009, 360: 1283-1297.CrossRef
6.
Qaseem A, Humphrey LL, Chou R, Snow V, Shekelle P: Use of intensive insulin therapy for the management of glycemic control in hospitalized patients: a clinical practice guideline from the American College of Physicians. Ann Intern Med 2011, 154: 260-267. 10.7326/0003-4819-154-4-201102150-00007CrossRefPubMed
7.
Meyfroidt G, Keenan DM, Wang X, Wouters PJ, Veldhuis JD, Van den Berghe G: Dynamic characteristics of blood glucose time series during the course of critical illness: effects of intensive insulin therapy and relative association with mortality. Crit Care Med 2010, 38: 1021-1029. 10.1097/CCM.0b013e3181cf710eCrossRefPubMed
8.
NICE-SUGAR Study Investigators, Finfer S, Liu B, Chittock DR, Norton R, Myburgh JA, McArthur C, Mitchell I, Foster D, Dhingra V, Henderson WR, Ronco JJ, Bellomo R, Cook D, McDonald E, Dodek P, Hébert PC, Heyland DK, Robinson BG: Hypoglycemia and risk of death in critically ill patients. N Engl J Med 2012, 367: 1108-1118.CrossRef
9.
Krinsley JS, Grover A: Severe hypoglycemia in critically ill patients: risk factors and outcomes. Crit Care Med 2007, 35: 2262-2267. 10.1097/01.CCM.0000282073.98414.4BCrossRefPubMed
10.
Hermanides J, Bosman RJ, Vriesendorp TM, Dotsch R, Rosendaal FR, Zandstra DF, Hoekstra JB, DeVries JH: Hypoglycemia is associated with intensive care unit mortality. Crit Care Med 2010, 38: 1430-1434. 10.1097/CCM.0b013e3181de562cCrossRefPubMed
11.
Krinsley JS, Schultz MJ, Spronk PE, Harmsen RE, van Braam Houckgeest F, van der Sluijs JP, Melot C, Preiser JC: Mild hypoglycemia is independently associated with increased mortality in the critically ill. Crit Care 2011, 15: R173. 10.1186/cc10322PubMedCentralCrossRefPubMed
12.
Egi M, Bellomo R, Stachowski E, French CJ, Hart G: Variability of blood glucose concentration and short-term mortality in critically ill patients. Anesthesiology 2006, 105: 244-252. 10.1097/00000542-200608000-00006CrossRefPubMed
13.
Krinsley JS: Glycemic variability: a strong independent predictor of mortality in critically ill patients. Crit Care Med 2008, 36: 3008-3013. 10.1097/CCM.0b013e31818b38d2CrossRefPubMed
14.
Hermanides J, Vriesendorp TM, Bosman RJ, Zandstra DF, Hoekstra JB, Devries JH: Glucose variability is associated with intensive care unit mortality. Crit Care Med 2010, 38: 838-842. 10.1097/CCM.0b013e3181cc4be9CrossRefPubMed
15.
Krinsley JS, Meyfroidt G, van den Berghe G, Egi M, Bellomo R: The impact of premorbid diabetic status on the relationship between the 3 domains of glycemic control and mortality in critically ill patients. Curr Opin Clin Nutr Metab Care 2012, 15: 151-160. 10.1097/MCO.0b013e32834f0009CrossRefPubMed
16.
Egi M, Bellomo R, Stachowski E, French CJ, Hart GK, Taori G, Hegarty C, Bailey M: The interaction of chronic and acute glycemia with mortality in critically ill patients with diabetes. Crit Care Med 2011, 39: 105-111. 10.1097/CCM.0b013e3181feb5eaCrossRefPubMed
17.
Finfer S, Wernermann J, Preiser JC, Cass T, Desavle T, Hovorka R, Joseph JI, Kosiborod M, Krinsley J, Mackenzie I, Mesotten D, Schultz M, Scott MG, Slingerland R, Van den Berghe G, Van Herpe T: Consensus recommendations on 'Measurement of blood glucose and reporting glycemic control in critically ill adults.'. Crit Care 2013, in press.
18.
Joseph JI, Hipszer B, Mraovic B, Chervoneva I, Joseph M, Grunwald Z: Clinical need for continuous glucose monitoring in the hospital. J Diabetes Sci Technol 2009, 3: 1309-1318.PubMedCentralCrossRefPubMed
Metadata
Title
Glycemic control in the critically ill - 3 domains and diabetic status means one size does not fit all!
Author
James S Krinsley
Publication date
01-04-2013
Publisher
BioMed Central
Published in
Critical Care / Issue 2/2013
Electronic ISSN: 1364-8535
DOI
https://doi.org/10.1186/cc12584

Other articles of this Issue 2/2013

Critical Care 2/2013 Go to the issue

Research

Dopexamine can attenuate the inflammatory response and protect against organ injury in the absence of significant effects on hemodynamics or regional microvascular flow

Commentary

Target blood pressure in sepsis: between a rock and a hard place

Research

Factors associated with outcomes of patients on extracorporeal membrane oxygenation support: a 5-year cohort study

Research

Glycyrrhizin protects against porcine endotoxemia through modulation of systemic inflammatory response

Research

Increased survival of cirrhotic patients with septic shock

Commentary

Optimizing safe, comfortable ICU care through multi-professional quality improvement: just DO it